Celljetics Income Disclosure
The Celljetics Compensation Plan is an exciting opportunity that rewards you for selling our proprietary dietary supplements and for sponsoring other participants who do the same. Although the opportunity is unlimited, individual results will vary depending on market conditions, commitment levels and sales skills of each participant.
Since Celljetics has recently launched, it lacks enough statistical data to prepare reliable income disclosures. The numbers below reflect estimates prepared by the company pending a more detailed survey to be conducted after its first year. Based on industry standards and company projections, the average annual gross revenue for IBPs is projected to be anywhere between $500 and $2,000. These numbers do not reflect the expenses associated with building a Celljetics business, which could exceed the commissions received.
There will certainly be participants who will earn less while others will earn much more. We’re excited about the Celljetics Compensation Plan and we’re confident it will provide you a solid foundation to help you achieve your financial goals.
If income projections were presented to you prior to your enrollment, such projections are not necessarily representative of the income, if any, that you can or will earn through your participation in the Compensation Plan. These income projections should not be considered as guarantees or projections of your actual earnings or profits. Success with Celljetics results only from hard work, dedication, and leadership.